Palatin Technologies, Inc.
$22.07
▲
3.02%
2026-04-21 08:59:01
palatin.com
ASE: PTN
Explore Palatin Technologies, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$39.22 M
Current Price
$22.07
52W High / Low
$31 / $2
Stock P/E
—
Book Value
$6.53
Dividend Yield
—
ROCE
478.76%
ROE
-3.79%
Face Value
—
EPS
$-8.26
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
29
Beta
-0.15
Debt / Equity
3.04
Current Ratio
2.76
Quick Ratio
0.36
Forward P/E
-7.33
Price / Sales
3.56
Enterprise Value
$17.81 M
EV / EBITDA
-1.44
EV / Revenue
1.99
Rating
None
Target Price
$54.33
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Cyclerion Therapeutics, Inc. | $3 | — | $13.08 M | — | -40.99% | -39.34% | $8.48 / $1.03 | $2.38 |
| 2. | GridAI Technologies Corp. | $2.79 | — | $9.38 M | — | -27% | -58.82% | $5.84 / $0.97 | — |
| 3. | Pliant Therapeutics, Inc. | $1.29 | — | $79.87 M | — | -74.87% | -61.55% | $1.95 / $1.09 | $2.95 |
| 4. | XORTX Therapeutics Inc. | $2.25 | — | $4.16 M | — | -156.2% | -98% | $9.85 / $2.42 | $0.3 |
| 5. | Disc Medicine, Inc. | $71.41 | — | $2.74 B | — | -30.64% | -35.86% | $99.5 / $39.2 | $19.52 |
| 6. | Vivani Medical, Inc. | $1.51 | — | $127.82 M | — | -84.04% | -1.6% | $1.92 / $0.92 | $0.21 |
| 7. | Contineum Therapeutics, Inc. | $13.47 | — | $524.38 M | — | -25.5% | -26.13% | $16.33 / $3.35 | $6.99 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.12 M | 8.85 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -7.33 M | 4.66 M | -4.6 M | -5.23 M | -5.11 M | — |
| Net Profit | -7.26 M | 4.68 M | -2.23 M | -4.81 M | -2.44 M | — |
| EPS in Rs | -4.1 | 2.64 | -1.26 | -2.71 | -1.38 | -19.71 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 4.49 M | 4.85 M | 1.47 M |
| Operating Profit | -22.71 M | -30.28 M | -33.49 M | -36.59 M |
| Net Profit | -17.31 M | -29.74 M | -24.04 M | -36.2 M |
| EPS in Rs | -9.77 | -16.78 | -13.56 | -20.43 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 3.27 M | 10.74 M | 17.94 M | 36.07 M |
| Total Liabilities | 8.04 M | 10.85 M | 19.92 M | 19.8 M |
| Equity | -4.78 M | -0.11 M | -1.98 M | 16.27 M |
| Current Assets | 2.92 M | 9.77 M | 16.32 M | 34.6 M |
| Current Liabilities | 8.01 M | 9.66 M | 15.13 M | 16.26 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -21.31 M | -31.46 M | -29.27 M | -29.92 M |
| Investing CF | 3.13 M | 12.45 M | -3.43 M | -0.26 M |
| Financing CF | 11.21 M | 20.55 M | 10.75 M | 0.02 M |
| Free CF | -21.31 M | -31.5 M | -29.71 M | -30.18 M |
| Capex | — | -0.04 M | -0.43 M | -0.26 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -7.49% | 230.53% | — | — |
| Earnings Growth % | -23.71% | 33.6% | — | — |
| Profit Margin % | -662.26% | -495.23% | -2465.06% | — |
| Operating Margin % | -674.33% | -689.91% | -2491.63% | — |
| Gross Margin % | 97.83% | 91.38% | 85.19% | — |
| EBITDA Margin % | -654.33% | -585.19% | -2454.41% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-08-12 | 1:0.02 |
| 2022-08-31 | 1:0.04 |